Immunotherapy of Melanoma
Immunotherapy of Melanoma
Bhandaru, Madhuri; Rotte, Anand
Springer International Publishing AG
01/2017
434
Dura
Inglês
9783319480657
15 a 20 dias
8734
Preface
1. Melanoma
1.1 Introduction, history and epidemiology
1.2 Diagnosis, subtypes and staging
1.3 Etiology
1.4 Treatment
2. Tumor immunology
2.1 Overview of immune system
2.2 Dendritic cells
2.3 T-cells
2.4 Mechanisms of immune evasion by cancer
3. Immune based drugs approved for treatment of melanoma<
3.1 IFN-?2b
3.2 IL-2
3.3 Ipilimumab
3.4 Nivolumab
3.5 Pembrolizumab
3.6 Talimogene laherparepvec
4. Promising immunotherapeutic approaches in clinical trials
4.1 Introduction
4.2 Monoclonal antibodies
4.3 Cytokines
4.4 Cancer vaccines
p; 4.5 Dendritic cells
4.6 Adoptive cell therapy
5. Challenges of immunotherapy
Index
Preface
1. Melanoma
1.1 Introduction, history and epidemiology
1.2 Diagnosis, subtypes and staging
1.3 Etiology
1.4 Treatment
2. Tumor immunology
2.1 Overview of immune system
2.2 Dendritic cells
2.3 T-cells
2.4 Mechanisms of immune evasion by cancer
3. Immune based drugs approved for treatment of melanoma<
3.1 IFN-?2b
3.2 IL-2
3.3 Ipilimumab
3.4 Nivolumab
3.5 Pembrolizumab
3.6 Talimogene laherparepvec
4. Promising immunotherapeutic approaches in clinical trials
4.1 Introduction
4.2 Monoclonal antibodies
4.3 Cytokines
4.4 Cancer vaccines
p; 4.5 Dendritic cells
4.6 Adoptive cell therapy
5. Challenges of immunotherapy
Index